Lung cancer continues to be one of the most common and deadly forms of cancer worldwide, leading to significant challenges in global healthcare. The lung cancer therapeutics market, valued at USD 31.92 billion in 2024, is poised for substantial growth, driven by the rising incidence of lung cancer and continuous advancements in therapeutic modalities. With a projected compound annual growth...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek